Gustavo Di Lallo, Mattia Falconi, Federico Iacovelli, Domenico Frezza, Pietro D'Addabbo
{"title":"Analysis of Four New <i>Enterococcus faecalis</i> Phages and Modeling of a Hyaluronidase Catalytic Domain from <i>Saphexavirus</i>.","authors":"Gustavo Di Lallo, Mattia Falconi, Federico Iacovelli, Domenico Frezza, Pietro D'Addabbo","doi":"10.1089/phage.2021.0003","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Phage therapy (PT), as a method to treat bacterial infections, needs identification of bacteriophages targeting specific pathogenic host. <i>Enterococcus faecalis</i>, a Gram-positive coccus resident in the human gastrointestinal tract, may become pathogenic in hospitalized patients showing acquired resistance to vancomycin and thus representing a possible target for PT. <b><i>Materials and Methods:</i></b> We isolated four phages that infect <i>E. faecalis</i> and characterized them by host range screening, transmission electron microscopy, and genome sequencing. We also identified and three-dimensional modeled a new hyaluronidase enzyme. <b><i>Results:</i></b> The four phages belong to <i>Siphoviridae</i> family: three <i>Efquatrovirus</i> (namely vB_EfaS_TV51, vB_EfaS_TV54, and vB_EfaS_TV217) and one <i>Saphexavirus</i> (vB_EfaS_TV16). All of them are compatible with lytic cycle. vB_EfaS_TV16 moreover presents a gene encoding for a hyaluronidase enzyme. <b><i>Conclusions:</i></b> The identified phages show features suggesting their useful application in PT, particularly the <i>Saphexavirus</i> that may be of enhanced relevance in PT because of its potential biofilm-digestion capability.</p>","PeriodicalId":74428,"journal":{"name":"PHAGE (New Rochelle, N.Y.)","volume":"2 3","pages":"131-141"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041502/pdf/phage.2021.0003.pdf","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PHAGE (New Rochelle, N.Y.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/phage.2021.0003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/9/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
Background: Phage therapy (PT), as a method to treat bacterial infections, needs identification of bacteriophages targeting specific pathogenic host. Enterococcus faecalis, a Gram-positive coccus resident in the human gastrointestinal tract, may become pathogenic in hospitalized patients showing acquired resistance to vancomycin and thus representing a possible target for PT. Materials and Methods: We isolated four phages that infect E. faecalis and characterized them by host range screening, transmission electron microscopy, and genome sequencing. We also identified and three-dimensional modeled a new hyaluronidase enzyme. Results: The four phages belong to Siphoviridae family: three Efquatrovirus (namely vB_EfaS_TV51, vB_EfaS_TV54, and vB_EfaS_TV217) and one Saphexavirus (vB_EfaS_TV16). All of them are compatible with lytic cycle. vB_EfaS_TV16 moreover presents a gene encoding for a hyaluronidase enzyme. Conclusions: The identified phages show features suggesting their useful application in PT, particularly the Saphexavirus that may be of enhanced relevance in PT because of its potential biofilm-digestion capability.